Dipyridamole (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Dipyridamole drug offered from Avera McKennan Hospital. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Dipyridamole |
| SUBSTANCE NAME: | DIPYRIDAMOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-11-17 |
| END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dipyridamole from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2015-11-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0428_854bb1dc-5bc5-480d-8d29-dc4bdbf173fa |
| PRODUCT NDC: | 69189-0428 |
| APPLICATION NUMBER: | ANDA087184 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:
